Insufficient Data
Insufficient Data
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Krebs Biochemicals and Industries Limited has informed the Exchange about intimation under regulation 30 of LODR regarding cessation of Ms.Taruni Banda as Company Secretary and Compliance officer w.e.f 6th August, 2022. | Download
Krebs Biochemicals and Industries Limited has informed the Exchange about intimation under regulation 30 of LODR regarding cessation of Ms.Taruni Banda as Company Secretary and Compliance officer w.e.f 6th August, 2022. | Download
Krebs Biochemicals and Industries Limited has informed the Exchange about Board Meeting held on 01-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters | Download
Krebs Biochemicals and Industries Limited has informed the Exchange about Board Meeting held on 01-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data